Genesis Pharma
Archived News Sitemap About this site Links Contact Us
Press Releases
  Press Releases
Archive
  Press Clippings
GENESIS Pharma is the sponsor of three significant events that
    contribute to the development of entrepreneurship

October 18th, 2004

GENESIS Pharma, one of the fastest growing biopharmaceutical companies in Greece supports the leading activities that contribute to the development of the Greek entrepreneurship, by sponsoring three significant events regarding Business Strategy, Developments in Marketing and Competitiveness, presented by distinguished scientists in the field.

More specifically, GENESIS Pharma sponsors:

  • Mr. Gary Hamel's speech entitled "Business Adaptability", aiming to prompt businesses towards constant adaptability into the new circumstances, in order to retain top positioning.
  • Mr. Philip Kotler's speech entitled "Philip Kotler on Marketing" aiming to introduce a reflection of the new trends in international Marketing.
  • "The Hour of Business Competitiveness", organized by the LONDON BUSINESS SCHOOL Alumni Association. The event took place in September, with main subject the competitiveness of Greek companies and their growth potential.

Mr. C. Evripides, GENESIS Pharma's CEO, stated: "It is a real honor for GENESIS Pharma to support such efforts towards the faster, healthier and more constant growth of Greek companies. Following current corporate trends is an inextricable part of GENESIS Pharma's business strategy"

GENESIS Pharma was incorporated in 1997, with the vision to substantially contribute to the treatment of life- threatening diseases. The company focuses on marketing, sales and distribution of specialised products emerging from biotechnology research for rare and chronic diseases. In reinforcing its role in the market, GENESIS Pharma has accomplished strategic alliances with top biopharmaceutical companies and has developed a strong regional presence in Greece and Southeast Europe. Today it represents top American and European companies of cellular and molecular technology such as Amgen, Biogen Idec, Chiron, Cephalon and Shire.

Print this page   Add to favorites  Send this page by e-mail
Copyright ©2004 GENESIS Pharma S.A. | Powered by ChannelDoubler Interactive Media | Last Update: 26/08/09